Gennex Laboratories Subsidiary Secures Manufacturing and Test Approvals in Andhra Pradesh
Gennex Laboratories Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 11:07 pm
Gennex Laboratories Subsidiary Secures Manufacturing and Test Approvals in Andhra Pradesh Gennex Laboratories announced that its subsidiary, Deccan Remedies Limited, received manufacturing and test licence approvals from the Drug Control Administration, Government of Andhra Pradesh. Under Form 25, the company secured manufacturing and sales approvals for domestic and export markets covering six additional products: Caffeine, Duloxetine Hydrochloride, Mebeverine Hydrochloride, Phenylephrine Hydrochloride, Trimebutine Maleate, and Oxyclozanide, valid until 28th May'28. Furthermore, it obtained a three-year Form 29 test licence for four drugs鈥擱anolazine, Cinnarizine, Sacubitril, and Triclabendazole鈥攖o conduct examination, testing, and chemical analysis.
Original exchange filing (PDF)
More announcements from Gennex Laboratories Ltd
- Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., November .... 路 15 Nov 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in their meeting held on November 14, 2026, reconstituted Audit .... 路 15 Nov 2026
- 1. Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30, 2026 along with the Statement of Assets and Liabilities as at September 30, .... 路 14 Nov 2026
- The Board of Directors of the Company at its meeting held today, i.e. Saturday, November 14, 2026 has considered and approved the following items: 1. Unaudited (Standalone and Consolidated) .... 路 14 Nov 2026
- Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve 1. Consider and adopt the .... 路 14 Nov 2026
- In compliance to Regulation 44 of SEBI (LODR) Regulations, 2015, as amended from time to time, please find enclosed herewith voting results of the 41st eAGM of the Company held on September .... 路 01 Oct 2026
- Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (LODR) Regulations, 2015, we would like to inform you that the Company has received approval of its members by Special .... 路 30 Sept 2026
- Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 41st eAGM of the Company held on Wednesday, September 30, 2026 through .... 路 30 Sept 2026
